Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE CENTRALE ILE ST LOUIS : revenue, balance sheet and financial ratios

SELARL PHARMACIE CENTRALE ILE ST LOUIS is a French company founded 21 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75004), this company of category PME shows in 2015 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE CENTRALE ILE ST LOUIS (SIREN 480342245)
Indicator 2022 2020 2015
Revenue N/C N/C 1 299 696 €
Net income 124 374 € 67 099 € 19 687 €
EBITDA N/C N/C 22 342 €
Net margin N/C N/C 1.5%

Revenue and income statement

In 2022, SELARL PHARMACIE CENTRALE ILE ST LOUIS generates positive net income of 124 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2022: 20 k€ -> 124 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

124 374 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 7%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 84%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

7.335%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

84.452%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

17.1%

Solvency indicators evolution
SELARL PHARMACIE CENTRALE ILE ST LOUIS

Sector positioning

Debt ratio
7.33 2022
2015
2020
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Excellent

In 2022, the debt ratio of SELARL PHARMACIE CENTRALE... (7.33) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
84.45% 2022
2015
2020
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Excellent

In 2022, the financial autonomy of SELARL PHARMACIE CENTRALE... (84.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
115.68 years 2015
2015
Q1: 2.13 years
Med: 6.76 years
Q3: 11.7 years
Watch

In 2015, the repayment capacity of SELARL PHARMACIE CENTRALE... (115.68) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 280.24. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

280.239

Liquidity indicators evolution
SELARL PHARMACIE CENTRALE ILE ST LOUIS

Sector positioning

Liquidity ratio
280.24 2022
2015
2020
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Excellent +54 pts over 3 years

In 2022, the liquidity ratio of SELARL PHARMACIE CENTRALE... (280.24) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
69.44x 2015
2015
Q1: 6.08x
Med: 13.88x
Q3: 23.76x
Excellent

In 2015, the interest coverage of SELARL PHARMACIE CENTRALE... (69.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 37 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 484 days. Excellent situation: suppliers finance 447 days of the operating cycle (retail model).

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

37 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

484 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE CENTRALE ILE ST LOUIS

Positioning of SELARL PHARMACIE CENTRALE ILE ST LOUIS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 215 transactions of similar company sales in 2022, the value of SELARL PHARMACIE CENTRALE ILE ST LOUIS is estimated at 1 463 447 € (range 983 727€ - 2 194 899€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
215 transactions
983k€ 1463k€ 2194k€
1 463 447 € Range: 983 727€ - 2 194 899€
NAF 5 année 2022

Valuation method used

Net Income Multiple
124 374 € × 11.8x = 1 463 448 €
Range: 983 728€ - 2 194 900€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE CENTRALE ILE ST LOUIS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE CENTRALE ILE ST LOUIS

What is the revenue of SELARL PHARMACIE CENTRALE ILE ST LOUIS ?

The revenue of SELARL PHARMACIE CENTRALE ILE ST LOUIS in 2015 is 1.3 M€.

Is SELARL PHARMACIE CENTRALE ILE ST LOUIS profitable?

Yes, SELARL PHARMACIE CENTRALE ILE ST LOUIS generated a net profit of 124 k€ in 2022.

Where is the headquarters of SELARL PHARMACIE CENTRALE ILE ST LOUIS ?

The headquarters of SELARL PHARMACIE CENTRALE ILE ST LOUIS is located in PARIS (75004), in the department Paris.

Where to find the tax return of SELARL PHARMACIE CENTRALE ILE ST LOUIS ?

The tax return of SELARL PHARMACIE CENTRALE ILE ST LOUIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE CENTRALE ILE ST LOUIS operate?

SELARL PHARMACIE CENTRALE ILE ST LOUIS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.